Chronic cardiac Chagas disease in Primary Health Care: experience report on the compulsory notification process and case classification
DOI:
https://doi.org/10.18310/2446-4813.2026v12nsup3.4920Keywords:
Chagas disease, Chagas Cardiomyopathy, Primary Health Care, Clinical TrialAbstract
Objective: to evaluate the feasibility of implementing a flow for diagnosis, notification and classification of cases of chronic cardiac Chagas disease in primary health care in the city of Patos de Minas, Minas Gerais. Experience report: The study participants were followed between September 2023 and June 2024. For compulsory notification of chronic Chagas disease, registration and subsequent release of access by a municipal, state or federal manager is required, which, in this experience, proved to be a bureaucratic, confusing and inefficient process. There was low adherence to confirmatory serological tests (16; 48.5%). There was also no complete adherence of the recruited patients to perform cardiological tests: electrocardiogram (31; 93.9%), chest X-ray (31; 93.9%) followed by echocardiogram (29; 87.9%) and Holter (24; 72.7%). There was one case of self-reported cardiac Chagas disease that had no serological confirmation and that did not have any cardiological damage. Patients' memory bias made it difficult to conduct research on aspects of disease onset, previous diagnosis, and other epidemiological aspects. These findings may be associated with the high mean age of patients (68.9 ± 9.5 years). In view of this, a protocol for diagnosing and monitoring chronic cardiac Chagas disease adapted to the local reality was proposed. Conclusion: The current reporting process may significantly impair estimates of the prevalence of chronic Chagas disease in the country. The low adherence of patients recruited for serological testing, associated with their advanced age, highlights the need for active search by health teams in communities, especially in areas of intense transmission in the past. Cardiological examinations are important for classifying cases in relation to risk of death, cardiac staging, and appropriate referral to different levels of health care.
References
1. Brasil. Ministério da Saúde. Guia de Vigilância em Saúde: volume 2 [Internet]. 6ª ed. Brasília: Ministério da Saúde; 2024 [citado 4 maio 2025]. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_v2_6edrev.pdf
2. Carvalho NB, Atala MM, Leite RM, Yasuda MAS. Manual de atendimento a pacientes com doença de Chagas: atenção básica 2014/2015. São Paulo: Faculdade de Medicina USP; 2018.
3. Martins-Melo FR, Ramos Jr AN, Alencar CH, Heukelbach J. Prevalence of Chagas disease in Brazil: a systematic review and meta-analysis. Acta Trop. 2014;130:167-74. doi:10.1016/j.actatropica.2013.10.002.
4. Dias JCP, Ramos Jr AN, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. II Consenso brasileiro em doença de Chagas, 2015. Epidemiol Serv Saude. 2016;25(spe):7-86. doi:10.5123/ s1679-49742016000500002.
5. Starfield B. Atenção Primária: equilíbrio entre necessidades de saúde, serviços e tecnologia. Brasília: UNESCO, Ministério da Saúde; 2002. p. 19-42.
6. Brasil. Ministério da Saúde. Portaria nº 1.061, de 18 de maio de 2020. Revoga a Portaria nº 264, de 17 de fevereiro de 2020, e altera a Portaria de Consolidação nº 4/GM/MS, de 28 de setembro de 2017, para incluir a doença de Chagas crônica, na Lista Nacional de Notificação Compulsória de doenças, agravos e eventos de saúde pública nos serviços de saúde públicos e privados em todo o território nacional. Diário Oficial da União, 2020.
7. Limongi JE, Peres TAF, Lima GLR, Soares LC, Gomes DC, del Prado IGN, et al. Megaesôfago e megacólon na Doença de Chagas: classificação de casos e possibilidades de atuação da Atenção Primária à Saúde. Rev APS 2021;24(Supl. 1):70-85. doi:10.34019/1809-8363.2021.v24.34983.
8. Peres TAF, Oliveira SV, Gomes DC, Del Prado IGN, Lima GLR, Soares LC, et al. Chronic Chagas cardiomyopathy: characterization of cases and possibilities of action of the primary healthcare. Cad Saude Publica. 2022;38(6):e00290321. doi:10.1590/0102-311XEN290321.
9. Xavier SS, Sousa AS, Hasslocher-Moreno A. Application of the new classification of cardiac insufficiency (ACC/AHA) in chronic Chagas cardiopathy: a critical analysis of the survival curves. Rev SOCERJ. 2005;18(3):227-32
10. Rassi Jr A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting mortality in Chagas’ heart disease. N Engl J Med. 2006;355(8):799-808.
11. Rassi Jr A, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007;115(9):1101-8
12. Brasil. Boletim Epidemiológico - Análise descritiva: um ano de implementação da notificação de doença de Chagas crônica no Brasil. Ministério da Saúde. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2024/boletim-epidemiologico-volume-55-no-08.pdf
13. Brasil. Ministério da Saúde. [Internet]. Guia para notificação de doença de Chagas crônica (DCC) E-SUS Notifica. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/doenca-de-chagas/guia-para-notificacao-de-doenca-de-chagas-cronicas-dcc/view
14. Cunha CLPD. Chagas Heart Disease: The Evolution of the Disease and its Complementary Exams. Arq Bras Cardiol. 2022;119(1):12-3.
15. Perissato IL, Santos KAR, Oliveira AMM, Limongi JE. Chagas disease and social welfare: characterization of the disease in the Brazilian social security and social assistance, 2004-2016. Epidemiol Serv Saude. 2022;31(2):e2021777. doi:10.1590/S2237-96222022000200006.
16. Limongi JE, Perissato IL, de Oliveira AMM, Santos KAR. Cardiac and digestive forms of chronic Chagas disease in Brazilian social welfare, 2004-2016. Rev Bras Med Trab. 2024;16;21(4):e20221038.
17. Limongi JE, Santos KAR, Perissato IL, Pinto RMC, Mendonça TMDS, Rinaldi AEM. Survival analysis of Chagas disease patients, beneficiaries of social security and social assistance in Brazil, 1942-2016. Rev Bras Epidemiol. 2024;17(27):e240020.
18. Limongi JE, Santos KAR, Perissato IL, Faria RM. Spatial analysis of granting of social welfare benefits to people with gastrointestinal Chagas disease in Brazil, 2004-2016: a time series study. Epidemiol Serv Saude. 2025;34:e20240622.
19. Brasil. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas da Doença de Chagas, no Âmbito do Sistema Único de Saúde-SUS. Brasília: Ministério da Saúde; 2018.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mateus Lopes de Faria, Daniela Nepomuceno Mello, Rivaldo Mauro Faria, Jean Ezequiel Limongi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais para artigos publicados neste periódico são do autor, com os direitos de publicação para o periódico. Este periódico é de acesso público, os artigos são de uso gratuito, com atribuições próprias, desde que citada a fonte (por favor, veja a Licença Creative Commons no link a seguir https://creativecommons.org/licenses/by/4.0/deed.pt_BR).